154 related articles for article (PubMed ID: 10342383)
1. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
[TBL] [Abstract][Full Text] [Related]
2. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells.
Higuchi Y; Nishikawa M; Kawakami S; Yamashita F; Hashida M
Int J Pharm; 2004 Dec; 287(1-2):147-54. PubMed ID: 15541921
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver.
Ogawara K; Nishikawa M; Takakura Y; Hashida M
J Control Release; 1998 Jan; 50(1-3):309-17. PubMed ID: 9685898
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.
Opanasopit P; Nishikawa M; Yamashita F; Takakura Y; Hashida M
J Drug Target; 2001; 9(5):341-51. PubMed ID: 11770704
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the molecular interaction between mannosylated proteins and serum mannan-binding lectins.
Terada T; Nishikawa M; Yamashita F; Hashida M
Int J Pharm; 2006 Jun; 316(1-2):117-23. PubMed ID: 16600536
[TBL] [Abstract][Full Text] [Related]
6. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
7. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
[TBL] [Abstract][Full Text] [Related]
8. Schwann cells express the macrophage mannose receptor and MHC class II. Do they have a role in antigen presentation?
Baetas-da-Cruz W; Alves L; Pessolani MC; Barbosa HS; Régnier-Vigouroux A; Corte-Real S; Cavalcante LA
J Peripher Nerv Syst; 2009 Jun; 14(2):84-92. PubMed ID: 19691530
[TBL] [Abstract][Full Text] [Related]
9. Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics.
Hirata K; Maruyama T; Watanabe H; Maeda H; Nakajou K; Iwao Y; Ishima Y; Katsumi H; Hashida M; Otagiri M
J Control Release; 2010 Jul; 145(1):9-16. PubMed ID: 20304018
[TBL] [Abstract][Full Text] [Related]
10. In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein.
Opanasopit P; Shirashi K; Nishikawa M; Yamashita F; Takakura Y; Hashida M
Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G879-89. PubMed ID: 11292596
[TBL] [Abstract][Full Text] [Related]
11. Morphological analysis of ligand uptake and processing: the role of multivesicular endosomes and CURL in receptor-ligand processing.
Harding C; Levy MA; Stahl P
Eur J Cell Biol; 1985 Mar; 36(2):230-8. PubMed ID: 2986980
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the mannose/fucose receptor on human mononuclear phagocytes.
Shepherd VL; Campbell EJ; Senior RM; Stahl PD
J Reticuloendothel Soc; 1982 Dec; 32(6):423-31. PubMed ID: 6298410
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
[TBL] [Abstract][Full Text] [Related]
14. Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells.
Magnusson S; Kjeken R; Berg T
Exp Cell Res; 1993 Mar; 205(1):118-25. PubMed ID: 8453986
[TBL] [Abstract][Full Text] [Related]
15. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice.
Katsumi H; Nishikawa M; Yasui H; Yamashita F; Hashida M
J Control Release; 2009 Nov; 140(1):12-7. PubMed ID: 19646492
[TBL] [Abstract][Full Text] [Related]
16. Processing of carcinoembryonic antigen by Kupffer cells: recognition of a penta-peptide sequence.
Gangopadhyay A; Thomas P
Arch Biochem Biophys; 1996 Oct; 334(1):151-7. PubMed ID: 8837750
[TBL] [Abstract][Full Text] [Related]
17. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
18. The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ.
Matsuo H; Funato K; Harashima H; Kiwada H
J Drug Target; 1994; 2(2):141-6. PubMed ID: 8069591
[TBL] [Abstract][Full Text] [Related]
19. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism.
Wilson ME; Pearson RD
J Immunol; 1986 Jun; 136(12):4681-8. PubMed ID: 3711662
[TBL] [Abstract][Full Text] [Related]
20. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
Jiang HL; Kang ML; Quan JS; Kang SG; Akaike T; Yoo HS; Cho CS
Biomaterials; 2008 Apr; 29(12):1931-9. PubMed ID: 18221992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
